Literature DB >> 19054276

Novel role for the delta-opioid receptor in hypoxic preconditioning in rat retinas.

Pai-Huei Peng1, Ho-Shiang Huang, Yih-Jing Lee, Yih-Sharng Chen, Ming-Chieh Ma.   

Abstract

Delta-opioid receptor (DOR) is an oxygen-sensitive protein whose function in the rat retina is unknown. We examined whether DOR is involved in hypoxic preconditioning (HPC)-mediated retinoprotection following intraocular pressure (IOP) elevation. Rats were exposed to intermittent hypoxia (10% oxygen) to induce HPC. Unilateral retinal ischemia/reperfusion injury was induced by elevating IOP to 100 mmHg for 1 h. HPC attenuated the loss of neuronal marker expression and increased pro-apoptotic caspase 3 activity in the IOP retina. Excess superoxide production and 8-iso-prostaglandin F2alpha accumulation caused by enhanced oxidant protein expression and reduced antioxidant enzyme level after IOP elevation were largely abrogated by HPC. HPC markedly increased the expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and DOR, but intravitreal administration of HIF-1alpha-specific small interfering RNA abrogated the up-regulation of DOR. This suggested that DOR functions downstream of HIF-1alpha. However, the endogenous content of leucine enkephalin in retinas was not affected by HPC or IOP. Treatment of retinas with the DOR antagonist naltrindole attenuated the HPC-induced protection and activation of extracellular signal-regulated kinase. These results suggest a novel mechanism of HPC-mediated retinoprotection whereby HIF-1alpha induces the expression of DOR, and DOR-mediated activation of extracellular signal-regulated kinase triggers cellular events that correct the redox imbalance in the post-ischemic retina.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19054276     DOI: 10.1111/j.1471-4159.2008.05807.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  25 in total

1.  Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model.

Authors:  Shahid Husain; Yasir Abdul; Craig E Crosson
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-28       Impact factor: 4.799

2.  beta-Endorphin expression in the mouse retina.

Authors:  Shannon K Gallagher; Paul Witkovsky; Michel J Roux; Malcolm J Low; Veronica Otero-Corchon; Shane T Hentges; Jozsef Vigh
Journal:  J Comp Neurol       Date:  2010-08-01       Impact factor: 3.215

Review 3.  Protecting motor networks during perinatal ischemia: the case for delta-opioid receptors.

Authors:  Stephen M Johnson; Sara M F Turner
Journal:  Ann N Y Acad Sci       Date:  2010-06       Impact factor: 5.691

4.  Dopaminergic amacrine cells express opioid receptors in the mouse retina.

Authors:  Shannon K Gallagher; Julia N Anglen; Justin M Mower; Jozsef Vigh
Journal:  Vis Neurosci       Date:  2012-05       Impact factor: 3.241

5.  Adaptive Plasticity in the Retina: Protection Against Acute Injury and Neurodegenerative Disease by Conditioning Stimuli.

Authors:  Jeffrey M Gidday
Journal:  Cond Med       Date:  2018-02-15

6.  Prolonged DADLE exposure epigenetically promotes Bcl-2 expression and elicits neuroprotection in primary rat cortical neurons via the PI3K/Akt/NF-κB pathway.

Authors:  Min Zhu; Ming Liu; Qi-Lin Guo; Cui-Qing Zhu; Jing-Chun Guo
Journal:  Acta Pharmacol Sin       Date:  2018-05-24       Impact factor: 6.150

Review 7.  Lipidic systems for in vivo siRNA delivery.

Authors:  Sherry Y Wu; Nigel A J McMillan
Journal:  AAPS J       Date:  2009-09-09       Impact factor: 4.009

8.  δ-Opioid receptors up-regulate excitatory amino acid transporters in mouse astrocytes.

Authors:  Jianfeng Liang; Dongman Chao; Harleen K Sandhu; Yanbing Yu; Li Zhang; Gianfranco Balboni; Dong H Kim; Ying Xia
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

Review 9.  Recent advances on the δ opioid receptor: from trafficking to function.

Authors:  Louis Gendron; Nitish Mittal; Hélène Beaudry; Wendy Walwyn
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 10.  Current research on opioid receptor function.

Authors:  Yuan Feng; Xiaozhou He; Yilin Yang; Dongman Chao; Lawrence H Lazarus; Ying Xia
Journal:  Curr Drug Targets       Date:  2012-02       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.